n-vinyl-2-pyrrolidinone has been researched along with Angiosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhuvaneswari, R; Chin, WW; Kho, KW; Olivo, M; Ong, KW; Soo, KC; Thong, PS | 1 |
| Bhuvaneswari, R; Chin, WW; Heng, PW; Hirt, W; Kuenzel, S; Olivo, M; Soo, KC; Thong, PS | 1 |
2 other study(ies) available for n-vinyl-2-pyrrolidinone and Angiosarcoma
| Article | Year |
|---|---|
Immune response against angiosarcoma following lower fluence rate clinical photodynamic therapy.
Topics: Chlorophyllides; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Immunity, Cellular; Lasers; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Porphyrins; Povidone; Protoporphyrins; Skin Neoplasms | 2008 |
Improved formulation of photosensitizer chlorin e6 polyvinylpyrrolidone for fluorescence diagnostic imaging and photodynamic therapy of human cancer.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chlorophyllides; Hemangiosarcoma; Humans; Image Processing, Computer-Assisted; Male; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Middle Aged; Neoplasms; Nonlinear Dynamics; Photochemotherapy; Photosensitizing Agents; Porphyrins; Povidone; Regression Analysis; ROC Curve; Spectrometry, Fluorescence; Tissue Distribution; Xenograft Model Antitumor Assays | 2008 |